id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2001-D-0007-0004,FDA,FDA-2001-D-0007,Biological Product Deviation Reporting for Blood and Plasma Establishments; Guidance for Industry; Availability,Notice,Notice of Availability,2020-03-13T04:00:00Z,2020,3,2020-03-13T04:00:00Z,,2020-03-13T14:56:32Z,2020-05103,0,0,0900006484441d07
FDA-2001-D-0007-0005,FDA,FDA-2001-D-0007,Biological Product Deviation Reporting for Blood and Plasma Establishments Guidance for Industry,Other,Guidance,2020-03-12T04:00:00Z,2020,3,2020-03-12T04:00:00Z,,2024-11-12T23:18:36Z,,1,0,09000064844428e1